Florida Attorney General Targets Chinese Medical Device Manufacturer Over Security Concerns

Florida Attorney General Targets Chinese Medical Device Manufacturer Over Security Concerns

This week, Florida’s Republican Attorney General James Uthmeier took a decisive legal step against a Chinese medical device manufacturer. The company, Contec Medical Systems Co., Ltd., faces serious allegations regarding the sale of medical devices deemed ‘compromised.’ These devices reportedly contain a backdoor that can be exploited by unauthorized users.

Subpoenas Issued to Contec Medical Systems

Contec, a medical device company based in China, has a sales operation in Florida. The Attorney General’s office issued subpoenas to the firm amidst pressing security concerns. In a recent press release, Uthmeier pointed out potential violations of state consumer protection law by Contec. He claims there is substantial evidence indicating that the company has been fabricating patient health monitors within the United States for over ten years, all while concealing critical security issues associated with its products.

Key Allegations Against Contec

Among the devices in question, the CMS800 patient monitoring device has been flagged for operating a backdoor. This allegation comes from both the Cybersecurity and Infrastructure Security Agency (CISA) and the U.S. Food and Drug Administration (FDA).

Uthmeier articulated the risks related to the CMS800, stating that it contains a built-in backdoor that actors with malicious intent might exploit to manipulate device data. Furthermore, the device reportedly transmits sensitive patient information to an IP address associated with a university in China. Such vulnerabilities raise alarming questions, especially given prior FBI warnings about cyber threats targeting U.S. healthcare systems. U.S. federal agencies have advised that these monitors should be disconnected or disabled.

Misrepresentation of FDA Approval

Another critical concern expressed by Uthmeier relates to Contec’s marketing practices. Contec and its distributors have reportedly misled consumers by promoting their devices as FDA-approved and compliant with international standards when, in fact, they do not meet these criteria.

Additionally, Uthmeier accused Epsimed, a Miami-based distributor of Contec’s monitors, of obscuring their sales activities by relabeling the devices as their own. Such actions could represent significant ethical and legal violations in the medical device industry.

Cooperation and Defense from Epsimed

In response to the subpoenas, Jose Mena, Epsimed’s CEO, has asserted the company’s complete cooperation. He confirmed that Epsimed has received the subpoenas issued by Uthmeier and emphasized their willingness to assist in the investigation.

Mena stated that the company does not sell these monitors within the United States, specifying that their client base is limited to Latin America. He added that the monitors are rarely used with an internet connection. For a monitor to pose a threat, it would require a Central Monitoring System, which Epsimed has never provided. The current use of the monitors is primarily as standalone devices, not connected to the internet. Upon learning about potential vulnerabilities with Contec monitors in January 2025, Epsimed promptly removed the products from their portfolio.

The Broader Implications of Uthmeier’s Legal Action

Uthmeier’s legal action marks the beginning of a broader initiative that could result in civil penalties, damages, or injunctive relief against both Contec and Epsimed. This move comes shortly after experts highlighted significant concerns about the potential for Chinese companies to facilitate sabotage against the U.S. The alarm bells were sounded following a notable drone strike by Israel on Iranian military sites, raising further questions about the capability of foreign entities to disrupt American safety.

Concerns About Foreign Influence

Public officials across the political spectrum have increasingly voiced apprehensions about China’s growing influence over land and assets crucial to American interests. This concern is grounded in the belief that such control could become a vulnerability in times of conflict.

Michael Lucci, CEO of State Armor Action, articulated a stark warning about this situation. He asserted that the U.S. must take substantial measures to mitigate risks associated with Chinese ownership of critical infrastructure and property holdings. Lucci’s comments reflect a deepening concern regarding national security and public safety in light of the growing ties between domestic companies and foreign entities.

Patient Safety and the Integrity of Medical Devices

Following Uthmeier’s legal action, Lucci emphasized the need for patients to feel secure when seeking medical care. There should be no anxiety surrounding the possibility that their medical devices are transmitting sensitive data back to the Chinese government. As the investigation unfolds, the implications of these allegations could resonate across the healthcare industry.

As stakeholders await further developments, both consumer protection and cybersecurity remain at the forefront of discussions surrounding medical technology. This case underscores the necessity for vigilance when it comes to the intersection of healthcare and national security issues.